ArticleMicrobial cell factories2025
Production of triacetic acid lactone from oleic acid by engineering the yeast Candida viswanathii.
Article in Microbial cell factories, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Triacetic acid lactone (TAL) is a promising platform chemical to produce valuable compounds. The development of engineered microbial hosts to efficiently produce TAL from lipid-containing waste streams could be a cost-effective, sustainable and environmentally friendly approach to meet the industrial demand. In this study, we engineered the yeast Candida viswanathii, possessing robust fatty acid conversion capabilities, to develop an alternative route for TAL production from fatty acids that aims to maximize conversion of the acetyl-CoA pool generated by β-oxidation in the peroxisome. To do so, we inactivated the carnitine acetyltransferase gene to block the transport of acetyl-CoA out of the peroxisome and overexpressed the enzymes methylmalonyl-CoA carboxyltransferase, 2-pyrone synthase and pyruvate carboxylase in the peroxisome to convert acetyl-CoA into TAL. We also performed an adaptive laboratory evolution experiment to obtain mutants with higher growth rate in medium with oleic acid and observed marked differences in central carbon metabolism and organic acid production pathways between the evolved and parental strains. These strains were further engineered by integrating additional copies of TAL biosynthetic genes while reducing competing reactions like ω-oxidation and Lipid biosynthesis, resulting in up to 50-fold increase in titers relative to the initial strain, reaching 280 mg/L. This study contributes to the development of bioprocesses that valorize fatty acids as microbial conversion substrates for the production of valuable compounds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.